Latest news, updates, and announcements from neuroClues.
neuroClues closed a €10M Series A, bringing total capital to €25M, to commercialise its CE‑marked eye‑tracking device that delivers AI‑derived neurological biomarkers in a 10‑minute exam. With 30+ uni...
